The pharmaceutical company Evita Solutions announced that last month the FDA approved its generic version of the abortion pill mifepristone. NBC News reporting on the FDA action said in part:
The FDA often issues a press release after new or significant drug approvals, but did not in this case....
Sen. Bill Cassidy, R-La., the chair of the Health, Education, Labor and Pensions Committee, which oversees the FDA chimed in on X: “I fully support President Trump’s Pro-Life, Pro-Family agenda, but the FDA approving one more tool to kill babies is a betrayal. This is not what Commissioner Makary and Secretary Kennedy indicated they would do in their confirmation hearings.”
